FDA hearing: psychedelics launch needs balanced regulation without limiting access
The area of psychedelic therapeutics has been rapidly growing in research and drug development with the advent of classical psychedelics…
The area of psychedelic therapeutics has been rapidly growing in research and drug development with the advent of classical psychedelics…
On 7 September at the European Respiratory Society (ERS) 2026 Annual Meeting, investigators from the University of Siena presented their…
On 7 September, at the European Respiratory Society (ERS) 2026 Annual Meeting, a group of investigators, which included both academic…
On Sunday, September 6, at the European Respiratory Society (ERS) 2026 Annual Meeting, Generate: Biomedicinesinvestigators presented pharmacodynamics and safety results…
On September 7, at the 2026 European Respiratory Society (ERS) International Congress in Barcelona, AstraZeneca presented results from an integrated…
Treatments targeting glucagon-like peptide-1 (GLP‑1) receptors have come to play a pivotal part in the tools available when treating patients…
On 28 August, at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany, a post-hoc analysis of the…
At the 2026 European Society of Cardiology (ESC) Scientific Sessions, hosted in Munich, Germany, researchers and care providers assembled to…
This year at the European Society of Cardiology (ESC) Scientific Sessions, findings from the ACACIA-HCM trial explored the effect of…
This year at the European Society of Cardiology (ESC) Scientific Sessions, new findings were presented from a pre-specified analysis of…